GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » Gross Profit

PharmChem (PharmChem) Gross Profit : $1.04 Mil (TTM As of Sep. 2023)


View and export this data going back to 2003. Start your Free Trial

What is PharmChem Gross Profit?

PharmChem's gross profit for the three months ended in Sep. 2023 was $1.04 Mil. PharmChem's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was $1.04 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. PharmChem's gross profit for the three months ended in Sep. 2023 was $1.04 Mil. PharmChem's Revenue for the three months ended in Sep. 2023 was $1.56 Mil. Therefore, PharmChem's Gross Margin % for the quarter that ended in Sep. 2023 was 66.18%.

PharmChem had a gross margin of 66.18% for the quarter that ended in Sep. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of PharmChem was 66.18%. The lowest was 11.04%. And the median was 27.97%.

Warning Sign:

PharmChem Inc gross margin has been in long-term decline. The average rate of decline per year is -9.2%.


PharmChem Gross Profit Historical Data

The historical data trend for PharmChem's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem Gross Profit Chart

PharmChem Annual Data
Trend Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.30 13.11 10.43 4.04 7.07

PharmChem Quarterly Data
Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Sep22 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 1.57 1.66 0.93 1.04

Competitive Comparison of PharmChem's Gross Profit

For the Diagnostics & Research subindustry, PharmChem's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmChem's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PharmChem's Gross Profit distribution charts can be found below:

* The bar in red indicates where PharmChem's Gross Profit falls into.



PharmChem Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

PharmChem's Gross Profit for the fiscal year that ended in Dec. 2002 is calculated as

Gross Profit (A: Dec. 2002 )=Revenue - Cost of Goods Sold
=30.085 - 23.013
=7.07

PharmChem's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=1.564 - 0.529
=1.04

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.04 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

PharmChem's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.04 / 1.564
=66.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PharmChem  (OTCPK:PCHM) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PharmChem had a gross margin of 66.18% for the quarter that ended in Sep. 2023 => Durable competitive advantage


PharmChem Gross Profit Related Terms

Thank you for viewing the detailed overview of PharmChem's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmChem (PharmChem) Business Description

Traded in Other Exchanges
N/A
Address
2411 E. Loop 820 N, Fort Worth, TX, USA, 76118
PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.
Executives
Alto Investors Palo 10 percent owner 470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp 10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire 08-11-2021